Secure your spot at the forefront of healthcare innovation. Join the waitlist today to be among the first to receive the DermaSensor device when it becomes available in your area. Elevate your practice with non-invasive, point-of-care skin cancer assessment, empowering you to make informed decisions and set your practice apart.
Don’t miss out – be part of the next wave in cutting-edge healthcare technology, for an introductory monthly subscription price of $199 (5 patients) or $399 (unlimited users and scans). No upfront device purchase is required. Device availability is expected this summer, so join the waitlist now!
Explore functionalities that combine cutting-edge AI technology with non-invasive cancer detection.
Be among the leaders in PCP skin cancer lesion assessments and reserve your DermaSensor device for your office today.
Set your practice apart by being one of the first PCPs in the U.S. to provide non-invasive, point-of-care skin cancer testing. DermaSensor empowers physicians by providing objective, actionable results to aid in skin cancer detection by assessing cellular and sub-cellular features that cannot be seen visually or dermoscopically.